Skip to content

Merging News

About
Contact
Home
Home
Privacy Policy

Merging News

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports – Reuters

Leave a Comment / Pharma and Biotech / By

Merck nears $6 billion buyout of Terns Pharma to boost cancer portfolio, FT reports Reuters

Source: news.google.com

← Previous Post

Related Posts

Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc – PR Newswire

Day One Biopharmaceuticals to Acquire Mersana Therapeutics – GlobeNewswire

Leave a Comment Cancel Reply

Your email address will not be published. Required fields are marked *

Type here..

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

Brazil’s Americanas files motion to exit bankruptcy protection proceedings – Reuters
Suncrete and Haymaker Acquisition Corp. 4 Announce Entering Into Non-Redemption Agreements with Certain Institutional Investors – PR Newswire
Crosby Enterprises, LLC Announces Voluntary Chapter 11 Filings to Facilitate Financial Restructuring for Three Subsidiaries – PR Newswire
GOWell Technology Limited and Inflection Point Acquisition Corp. V Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination – GlobeNewswire
Pelican Acquisition Corporation (NASDAQ: PELI) Announces – GlobeNewswire

Recent Comments

No comments to show.

Archives

March 2026
February 2026
January 2026
December 2025
November 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
April 2025
March 2025

Categories

Bankruptcy
Energy and Materials
Financial Services
Mega Deals
Pharma and Biotech
Tech and Software

About
Contact
Home
Home
Privacy Policy

Sign up to receive email updates, fresh news and more!

There was an error trying to submit your form. Please try again.

This field is required.

There was an error trying to submit your form. Please try again.

Copyright © 2026 Merging News | Powered by Merging News